StonvexLoading…
StonvexStonvexStonvexCore line items from CELU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $26.55M | $22.45M | $17.16M | $11.43M |
Operating Income | $-61.31M | $-39.25M | $-26.35M | $-10.49M |
Net Income | $-91.72M | $-67.35M | $-24.52M | $-19.75M |
EPS (Diluted) | $-3.59 | $-2.74 | $-1.86 | $-0.84 |
Total Assets | $107.33M | $114.24M | $120.28M | $128.88M |
Total Liabilities | $145.39M | $134.33M | $145.78M | $134.38M |
Cash & Equivalents | $6.17M | $120.00K | $863.00K | $293.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 28.84M | 28.22M | 24.61M | 23.94M |